Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
4(40%)
Results Posted
75%(3 trials)

Phase Distribution

Ph not_applicable
5
50%
Ph phase_2
1
10%
Ph early_phase_1
1
10%
Ph phase_1
2
20%
Ph phase_3
1
10%

Phase Distribution

3

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 1Safety & dosage
2(20.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
5(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Recruiting3
Active, not recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (10.0%)
Phase 12 (20.0%)
Phase 21 (10.0%)
Phase 31 (10.0%)
N/A5 (50.0%)

Trials by Status

completed440%
active_not_recruiting110%
unknown110%
withdrawn110%
recruiting330%

Recent Activity

4 active trials
Showing 5 of 10
recruitingphase_2

Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasound in Patients With Locally Advanced Breast Cancer

NCT04715958
recruitingphase_1

Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses

NCT06171607
recruitingnot_applicable

Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension

NCT06797193
active_not_recruitingphase_3

Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)

NCT05336786
completedearly_phase_1

Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery

NCT03297112
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04715958Phase 2

Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasound in Patients With Locally Advanced Breast Cancer

Recruiting
NCT06171607Phase 1

Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses

Recruiting
NCT06797193Not Applicable

Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension

Recruiting
NCT05336786Phase 3

Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)

Active Not Recruiting
NCT03297112Early Phase 1

Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery

Completed
NCT03045497Phase 1

Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads

Completed
NCT02424955Not Applicable

Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation

Completed
NCT03300401Not Applicable

Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization

Withdrawn
NCT00584402Not Applicable

Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation

Completed
NCT00631553Not Applicable

Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10